Table II.

Treatment and outcome information for the eight patients with a fungal prosthetic joint infection.

Case No.	Surgery/outcome	Antimicrobial saturated in cement/duration in joint	Antimicrobials/duration	Pre/post-op Harris or HSS	Follow-up duration/results
1	Two-stage revision/success	4 g Van/40 g/3 Mon	After spacer, Flu/1.5 Mon after revision, Flu/1 Mon	48/92	3.3 Y/No recurrence
2	Two-stage revision/failure two-stage revision/success	2nd spacer 4.8 g Van/40 g/3.6 Mon	After 2nd spacer, Flu/1.5 Mon after 2nd revision, Flu/1 Mon	45/87	6.6 Y/No recurrence
3	Two-stage revision/success	4 g Van+2 g Mer/40 g/4.5 Mon	Pre-op Flu, Vor/1 Mon after spacer, Flu/4 Mon after revision, Flu/1Mon	43/86	5.1 Y/No recurrence
4	Spacer implantation/failure resection arthroplasty/success	4.8 g Van/40 g/6 Mon	After spacer, Flu/3 Mon, Amp/2 Mon after resection arthroplasty Cas/46 days	37/62	2.9 Y/No recurrence before death
5	Two-stage revision/success	3 g Van+1 g Mer/40 g/3 Mon	After spacer, Flu/1.5 Mon after revision, Flu/1 Mon	46/89	3.7 Y/No recurrence
6	Two-stage revision/success	4 g Van/40 g/3 Mon	After spacer, Flu/1.5 Mon after revision, Cas/1 Mon	35/91	4.7 Y/No recurrence
7	Two-stage revision/success	3 g Van+1 g Mer/40 g/7 Mon	After spacer, Flu/6 Mon after revision, Flu/1 Mon	40/91	5.2 Y/No recurrence
8	Two-stage revision/success	2 g Van+200 mg Amp/40 g/4 Mon	After spacer, Flu/1.5 Mon after revision, Flu/1 Mon	55/90	4 Y/No recurrence

Pre-op, preoperative; Post-op, postoperative; Mon, months; W, week; Y, year; Flu, fluconazol; Vor, voriconazole; Amp, Amphotericin B; Cas, caspofungin; Van, vancomycin, Mer, Meropenem; HSS, Hospital for Special Surgery.